Shunde Innovation School, Research Institute of Biology and Agriculture, University of Science and Technology Beijing, Beijing, 100083, China.
Zhongzhi International Institute of Agricultural Biosciences, Beijing, 100083, China.
Cell Commun Signal. 2024 Jan 30;22(1):84. doi: 10.1186/s12964-023-01419-3.
Alzheimer's disease (AD), affecting many elders worldwide, is characterized by A-beta and tau-related cognitive decline. Accumulating evidence suggests that brain iron accumulation is an important characteristic of AD. However, the function and mechanism of the iron-mediated gut-brain axis on AD is still unclear.
A Caenorhabditis elegans model with tau-overexpression and a high-Fe diet mouse model of cognitive impairment was used for probiotic function evaluation. With the use of qPCR, and immunoblotting, the probiotic regulated differential expression of AD markers and iron related transporting genes was determined. Colorimetric kits, IHC staining, and immunofluorescence have been performed to explore the probiotic mechanism on the development of gut-brain links and brain iron accumulation.
In the present study, a high-Fe diet mouse model was used for evaluation in which cognitive impairment, higher A-beta, tau and phosphorylated (p)-tau expression, and dysfunctional phosphate distribution were observed. Considering the close crosstalk between intestine and brain, probiotics were then employed to delay the process of cognitive impairment in the HFe mouse model. Pediococcus acidilactici (PA), but not Bacillus subtilis (BN) administration in HFe-fed mice reduced brain iron accumulation, enhanced global alkaline phosphatase (AP) activity, accelerated dephosphorylation, lowered phosphate levels and increased brain urate production. In addition, because PA regulated cognitive behavior in HFe fed mice, we used the transgenic Caenorhabditis elegans with over-expressed human p-tau for model, and then PA fed worms became more active and longer lived than E.coli fed worms, as well as p-tau was down-regulated. These results suggest that brain iron accumulation influences AD risk proteins and various metabolites. Furthermore, PA was shown to reverse tau-induced pathogenesis via iron transporters and AP-urate interaction.
PA administration studies demonstrate that PA is an important mediator of tau protein reduction, p-tau expression and neurodegenerative behavior both in Caenorhabditis elegans and iron-overload mice. Finally, our results provide candidates for AP modulation strategies as preventive tools for promoting brain health. Video Abstract.
阿尔茨海默病(AD)影响着全球众多老年人,其特征是 A-β 和 tau 相关的认知能力下降。越来越多的证据表明,脑铁积累是 AD 的一个重要特征。然而,铁介导的肠脑轴在 AD 中的作用和机制尚不清楚。
使用过表达 tau 和高铁饮食的认知障碍小鼠模型评估益生菌的功能。通过 qPCR 和免疫印迹确定益生菌对 AD 标志物和铁相关转运基因的差异表达的调节作用。使用比色试剂盒、免疫组化染色和免疫荧光法探索益生菌对肠道-大脑联系和脑铁积累发展的作用机制。
在本研究中,使用高铁饮食小鼠模型进行评估,观察到认知障碍、更高的 A-β、tau 和磷酸化(p)-tau 表达以及磷酸化分布功能障碍。考虑到肠道和大脑之间的密切相互作用,然后使用益生菌来延缓 HFe 小鼠模型中的认知障碍进程。在 HFe 喂养的小鼠中,嗜酸乳杆菌(PA)而不是枯草芽孢杆菌(BN)的给药减少了脑铁积累,增强了整体碱性磷酸酶(AP)活性,加速了去磷酸化,降低了磷酸水平,并增加了脑尿酸生成。此外,由于 PA 调节了 HFe 喂养小鼠的认知行为,我们使用了过表达人 p-tau 的转基因秀丽隐杆线虫模型,然后发现 PA 喂养的线虫比 E.coli 喂养的线虫更活跃、寿命更长,p-tau 表达水平降低。这些结果表明,脑铁积累会影响 AD 风险蛋白和各种代谢物。此外,PA 被证明通过铁转运体和 AP-尿酸相互作用来逆转 tau 诱导的发病机制。
PA 给药研究表明,PA 是秀丽隐杆线虫和铁过载小鼠中 tau 蛋白减少、p-tau 表达和神经退行性行为的重要调节剂。最后,我们的研究结果为 AP 调节策略提供了候选药物,作为促进大脑健康的预防工具。